Trial Profile
Prospective, randomized, double-blinded split-face study comparing efficacy of treatment of benign essential blepharospasm by Xeomin vs Botox
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm
- Focus Therapeutic Use
- 03 Nov 2015 New trial record